Groundbreaking Drug Offers Significant Benefits for Parkinson's Patients #South_Korea #Seoul #FDA_Approval #Parkinson's_Disease #Solengepras
@newsen.bsky.social
@newsen.bsky.socialGroundbreaking Drug Offers Significant Benefits for Parkinson's Patients #South_Korea #Seoul #FDA_Approval #Parkinson's_Disease #Solengepras
When Parkinson’s medicine wears off, everyday movement can become harder. Doctors call this “OFF time”. A new tablet being researched reduced it by about 37 minutes a day on average versus a dummy tablet. It isn’t UK-approved and full results are still needed. #Parkinsons #Solengepras